乐观
$494.79
情景价格
$457.470
+15.142 (+3.31%)收盘时
Waters Corporation is a global life sciences and diagnostics company. The Company offers analytical instruments, separations technologies, and software, serving life, materials, food, and environmental sciences. Its segments include Waters and TA. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. The Company designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments through its TA Instruments (TA) product line. The Company is also a developer and supplier of advanced software-based products that interface with the Company’s instruments, as well as other manufacturers’ instruments.
Currently, Waters Corp (WAT) is a hold. The stock is priced at $436.95, with a forward P/E of 24.75, indicating a reasonable valuation for growth potential. However, the recent negative trend in insider selling, which increased by 125.80%, raises concerns about confidence from company insiders. The RSI is at 53.60, suggesting the stock is neither overbought nor oversold, which aligns with a cautious approach at this time.
BofA
$465
2026-10-09
BofA
2026-10-09
目标价
$465
Barclays
$500
2026-10-07
Barclays
2026-10-07
目标价
$500
Guggenheim
$490
2026-10-01
Guggenheim
2026-10-01
目标价
$490
Goldman Sachs
$515
2026-09-21
Goldman Sachs
2026-09-21
目标价
$515
UBS
$490
2026-09-09
UBS
2026-09-09
目标价
$490
情景价格取自当年最后一个月度预测区间。概率为固定的模型权重(25 / 50 / 25),不构成保证。

Healthcare Sector Gains Investor Attention Amid Market Rotation

IMU Collaborates with UK Biobank for Immune Data Profiling

Waters Launches AI Link Software to Drive Laboratory Automation

Market Outlook: Tech Stock Dynamics and Investment Opportunities

Waters Launches BD FACSDiscover A7 Cell Analyzer for Enhanced Flow Cytometry
Waters Corporation is a global life sciences and diagnostics company. The Company offers analytical instruments, separations technologies, and software, serving life, materials, food, and environmental sciences. Its segments include Waters and TA. The Company primarily designs, manufactures, sells and services high-performance liquid chromatography (HPLC), ultra-performance liquid chromatography (UPLC and together with HPLC, referred to as LC) and mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products and comprehensive post-warranty service plans. The Company designs, manufactures, sells and services thermal analysis, rheometry and calorimetry instruments through its TA Instruments (TA) product line. The Company is also a developer and supplier of advanced software-based products that interface with the Company’s instruments, as well as other manufacturers’ instruments. It operates in the Healthcare sector (LABORATORY ANALYTICAL INSTRUMENTS industry).
Currently, Waters Corp (WAT) is a hold. The stock is priced at $436.95, with a forward P/E of 24.75, indicating a reasonable valuation for growth potential. However, the recent negative trend in insider selling, which increased by 125.80%, raises concerns about confidence from company insiders. The RSI is at 53.60, suggesting the stock is neither overbought nor oversold, which aligns with a cautious approach at this time.
15 analysts cover WAT: 5 rate it Buy, 9 Hold and 1 Sell. The average price target is 414.08.
暂无帖子
注册或登录后参与讨论本页仅供研究参考,不构成投资建议。模型可能出错。过往表现不代表未来结果。